| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/30/2009 | US20090193537 Pea line crescendo |
| 07/30/2009 | US20090193536 Pea line 08240773 |
| 07/30/2009 | US20090193533 Conditional-Stop Dimerizable Caspase Transgenic Animals |
| 07/30/2009 | US20090193531 Methods and compositions for RNA Interference |
| 07/30/2009 | US20090193530 Animals, cells and methods for production of detectably-labeled antibodies |
| 07/30/2009 | US20090192294 Magi polynucleotides, polypeptides, and antibodies |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192290 New bacillus thuringiensis strains and their insecticidal proteins |
| 07/30/2009 | US20090192170 N-((S)-1-cyclopentyl-2-oxo-2-((3aS,6aR)-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)ethyl)-4-(4-methylpiperazin-1-yl)benzamide; osteoporosis, Paget's disease, Chagas's, malaria, gingival diseases, hypercalcemia, metabolic bone disease, bone cancer and associated pain |
| 07/30/2009 | US20090192117 Compositions and methods for the suppression of target polynucleotides from lygus |
| 07/30/2009 | US20090192116 Compositions and methods for the suppression of target polynucleotides from the family aphididae |
| 07/30/2009 | US20090192112 Compositions and methods for treating cancer |
| 07/30/2009 | US20090192108 Gene overexpressed in cancer |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192087 Methods and Compositions Using Klotho-FGF Fusion Polypeptides |
| 07/30/2009 | US20090192084 Compositions and method of treating hypoxia-associated diseases |
| 07/30/2009 | US20090192082 Cxcr4 antagonist treatment of hematopoietic cells |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090192072 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 07/30/2009 | US20090192039 Wheat plants having increased resistance to imidazolinone herbicides |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191636 Method of Producing Transgenic Graminaceous Cells and Plants |
| 07/30/2009 | US20090191635 Plant egg cell transcriptional control sequences |
| 07/30/2009 | US20090191634 (meth)acrylate surfaces for cell culture, methods of making and using the surfaces |
| 07/30/2009 | US20090191633 Synthetic Surfaces for Culturing Stem Cell Derived Cardiomyocytes |
| 07/30/2009 | US20090191632 Swellable (meth)acrylate surfaces for culturing cells in chemically defined media |
| 07/30/2009 | US20090191631 3-D petri-dish for the culture and studies of cells |
| 07/30/2009 | US20090191630 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 07/30/2009 | US20090191629 Mammalian chemokine reagents |
| 07/30/2009 | US20090191628 Methods for co-culturing cord blood derived cells with menstrual stem cells |
| 07/30/2009 | US20090191627 Synthetic surfaces for culturing cells in chemically defined media |
| 07/30/2009 | US20090191626 Synthetic Surfaces for Culturing Stem Cell Derived Oligodendrocyte Progenitor Cells |
| 07/30/2009 | US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins |
| 07/30/2009 | US20090191622 Synthetic nucleic acids from aquatic species |
| 07/30/2009 | US20090191610 Microorganisms With Increased Efficiency for Methionine Synthesis |
| 07/30/2009 | US20090191608 Pancreatic Islet Cell Preparation and Transplantation |
| 07/30/2009 | US20090191606 Organic compounds |
| 07/30/2009 | US20090191597 Enhanced production of infectious parvovirus vectors in insect cells |
| 07/30/2009 | US20090191591 Taurine Transporter Gene |
| 07/30/2009 | US20090191588 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav |
| 07/30/2009 | US20090191584 Transcriptional repression of sodium-iodide symporter in thyroid carcinoma |
| 07/30/2009 | US20090191583 Clostridial toxin activity assays |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191569 Mammalian Cytokines; Related Reagents |
| 07/30/2009 | US20090191555 HCV NS3-NS4 Protease Resistance Mutants |
| 07/30/2009 | US20090191552 Novel Human Acidic Mammalian Chitinase and Use Thereof |
| 07/30/2009 | US20090191543 Identification of rac1b as a marker and mediator of metalloproteinase-induced malignancy |
| 07/30/2009 | US20090191542 Multi-variant cell indication technique |
| 07/30/2009 | US20090191540 Markers for Viral Infections and Other Inflammatory Responses |
| 07/30/2009 | US20090191534 System and sequential culture media for in vitro fertilization |
| 07/30/2009 | US20090191269 Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition |
| 07/30/2009 | US20090191263 Compositions and methods for sirna inhibition of hif-1 alpha |
| 07/30/2009 | US20090191235 Conformationally stabilized hiv envelope immunogens and triggering hiv-1 envelope to reveal cryptic v3-loop epitopes |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191222 Metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression |
| 07/30/2009 | US20090191221 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 07/30/2009 | US20090191214 Anti-human il-21 monoclonal antibodies |
| 07/30/2009 | US20090191213 Compositions and methods for regulating NK cell activity |
| 07/30/2009 | US20090191211 METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES |
| 07/30/2009 | US20090191210 Method for inhibiting tumor invasion or spreading in a subject |
| 07/30/2009 | US20090191209 Methods and compositions for targeting polyubiquitin |
| 07/30/2009 | US20090191206 Human Semen Enhancer of Viral Infection Peptides (SEVI) and Their Use |
| 07/30/2009 | US20090191205 Compositions and Methods for Treating and Diagnosing Cancer |
| 07/30/2009 | US20090191204 Anti-psgl-1 antibodies |
| 07/30/2009 | US20090191202 Methods for manipulating phagocytosis mediated by CD47 |
| 07/30/2009 | US20090191199 Glycoengineered, recombinant antibody |
| 07/30/2009 | US20090191198 Methods for blocking the interaction between nkp80 and its ligands |
| 07/30/2009 | US20090191197 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191192 Humanized anti-ccr2 antibodies and methods of use therefor |
| 07/30/2009 | US20090191190 Anti-ABeta Globulomer Antibodies, Antigen-Binding Moieties Thereof, Corresponding Hybridomas, Nucleic Acids, Vectors, Host Cells, Methods of Producing Said Antibodies, Compositions Comprising Said Antibodies, Uses Of Said Antibodies And Methods Of Using Said Antibodies |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191187 Antibodies against interleukin-1 receptor and uses thereof |
| 07/30/2009 | US20090191182 Compositions, Kits, and Methods for the Modulation of Immune Responses Using Galectin-1 |
| 07/30/2009 | US20090191178 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
| 07/30/2009 | US20090191174 Blood processing device and associated systems and methods |
| 07/30/2009 | US20090191172 Method of Controlling Administration of Cancer Antigen |
| 07/30/2009 | US20090191171 Reprogramming of Differentiated Progenitor or Somatic Cells Using Homologous Recombination |
| 07/30/2009 | US20090191170 Nucleic acid compositions and methods of introducing nucleic acids into cells |
| 07/30/2009 | US20090191169 Methods for gene transfer to mammals |
| 07/30/2009 | US20090191166 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 07/30/2009 | US20090191164 Human hematopoietic multipotent progenitor cells |
| 07/30/2009 | US20090191163 Primed tissue for tissue engineering and methods of priming tissue |
| 07/30/2009 | US20090191162 Catecholamine Receptor Modulation |
| 07/30/2009 | US20090191161 Tenocyte cell culturing method |
| 07/30/2009 | US20090191160 Methods of producing pluripotent stem-like cells |
| 07/30/2009 | US20090191159 Multipotent/pluripotent cells and methods |
| 07/30/2009 | US20090191127 Omentum and use thereof |
| 07/30/2009 | US20090191120 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191119 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | US20090190135 CELL CULTURE HYDROGEL WITH pH INDICATOR |
| 07/30/2009 | CA2712745A1 Pancreatic islet cell preparation and transplantation |
| 07/29/2009 | EP2083084A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 07/29/2009 | EP2083079A1 Apo-2DcR |
| 07/29/2009 | EP2083076A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 07/29/2009 | EP2083075A1 Process for conversion of germplasm |
| 07/29/2009 | EP2083074A1 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |
| 07/29/2009 | EP2083073A1 Reagent containing fused protein of soluble rankl with epitope tag |
| 07/29/2009 | EP2083072A1 Stem-regulated, plant defense promotor and uses thereof in tissue-specific expression in monocots |